Acute Phase Reactant in Non-COVID-19 Bacterial Pneumonia
1 other identifier
observational
51
1 country
1
Brief Summary
This study is a cross-sectional study, was conducted at Chest department of Kasr Al-ainy Hospital, Cairo university during the period between October 2020 and April 2021. The aim of the work was to evaluate levels of acute phase reactants(APR) in Non-COVID-19 bacterial pneumonia, and to correlate between levels of APR and the disease severity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2021
CompletedFirst Submitted
Initial submission to the registry
June 28, 2023
CompletedFirst Posted
Study publicly available on registry
July 3, 2023
CompletedJuly 14, 2023
July 1, 2023
7 months
June 28, 2023
July 12, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
measurement of APR levels in non-Covid-19 pneumonia
assessment of the level of APR and its relation to disease severity
6 months
Interventions
blood sampling to measure APR
Eligibility Criteria
All patients( 51 patients diagnosed as non-COVID19 Pneumonia) were subjected to: 1. Full historywith emphasis on: * Epidemiological features . * Risk factors (smoking, DM). * Clinical presentation (cough, Fever and duration of ilness). 2. Clinical examination (local chest examination). 3. Laboratory investigations: venous blood samples were taken for:• Complete blood picture, differential leucocytic count and platelets count, ESR ,CRP, d-dimer and ferritin
You may qualify if:
- COVID-19 negative bacterial pneumonia
You may not qualify if:
- COVID-19 positive
- other non-pulmonary infections
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Kasr alainy school of medicine
Cairo, 11562, Egypt
Biospecimen
• Complete blood picture, differential leucocytic count and platelets count: Done by The newly developed automated hematology analyzer (Sysmex, Kobe, Japan) enumerates and classifies blood cells by a combination of direct current detection and flow cytometry. (Daves et al., 2015).
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of pulmonology
Study Record Dates
First Submitted
June 28, 2023
First Posted
July 3, 2023
Study Start
October 1, 2020
Primary Completion
April 30, 2021
Study Completion
May 30, 2021
Last Updated
July 14, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will not share